{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T02:45:54Z","timestamp":1785206754525,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1F30CA257365-01"],"award-info":[{"award-number":["1F30CA257365-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Epithelial ovarian cancer (OC) is the most lethal gynecological malignancy and patients present with significant metastatic burden, particularly to the adipose-rich microenvironment of the omentum. Recent evidence has highlighted the importance of metabolic adaptations in enabling this metastasis, leading to significant interest in evolving the arsenal of tools used to study OC metabolism. In this study, we demonstrate the capability of genetically encoded fluorescent biosensors to study OC, with a focus on 3D organoid models that better recapitulate in vivo tumor microenvironments.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>Plasmids encoding the metabolic biosensors HyPer, iNap, Peredox, and Perceval were transfected into 15 ovarian cancer cell lines to assay oxidative stress, NADPH\/NADP+, NADH\/NAD+, and ATP\/ADP, respectively. Fluorescence readings were used to assay dynamic metabolic responses to omental conditioned media (OCM) and 100\u2009\u03bcM carboplatin treatment. SKOV3 cells expressing HyPer were imaged as 2D monolayers, 3D organoids, and as in vivo metastases via an intravital omental window. We further established organoids from ascites collected from Stage III\/IV OC patients with carboplatin-resistant or carboplatin-sensitive tumors (<jats:italic>n<\/jats:italic>\u2009=\u20098 total). These patient-derived organoids (PDOs) were engineered to express HyPer, and metabolic readings of oxidative stress were performed during treatment with 100\u2009\u03bcM carboplatin.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Exposure to OCM or carboplatin induced heterogenous metabolic changes in 15 OC cell lines, as measured using metabolic sensors. Oxidative stress of in vivo omental metastases, measured via intravital imaging of metastasizing SKOV3-HyPer cells, was more closely recapitulated by SKOV3-HyPer organoids than by 2D monolayers. Finally, carboplatin treatment of HyPer-expressing PDOs induced higher oxidative stress in organoids derived from carboplatin-resistant patients than from those derived from carboplatin-sensitive patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our study showed that biosensors provide a useful method of studying dynamic metabolic changes in preclinical models of OC, including 3D organoids and intravital imaging. As 3D models of OC continue to evolve, the repertoire of biosensors will likely serve as valuable tools to probe the metabolic changes of clinical importance in OC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13048-022-01046-5","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T16:05:19Z","timestamp":1666281919000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Using genetically encoded fluorescent biosensors to interrogate ovarian cancer metabolism"],"prefix":"10.1186","volume":"15","author":[{"given":"Shree","family":"Bose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haipei","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Whitaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Kontos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Previs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiling","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,20]]},"reference":[{"issue":"9","key":"1046_CR1","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1002\/ijc.34002","volume":"151","author":"CJ Cabasag","year":"2022","unstructured":"Cabasag CJ, et al. Ovarian cancer today and tomorrow: a global assessment by world region and human development index using GLOBOCAN 2020. Int J Cancer. 2022;151(9):1535\u201341.","journal-title":"Int J Cancer."},{"issue":"1","key":"1046_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-9966-31-14","volume":"31","author":"A Kim","year":"2012","unstructured":"Kim A, et al. Therapeutic strategies in epithelial ovarian cancer. J Exp Clin Cancer Res. 2012;31(1):1\u20138.","journal-title":"J Exp Clin Cancer Res"},{"issue":"11","key":"1046_CR3","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/nm.2492","volume":"17","author":"KM Nieman","year":"2011","unstructured":"Nieman KM, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med. 2011;17(11):1498\u2013503.","journal-title":"Nat Med"},{"issue":"16","key":"1046_CR4","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1038\/s41388-018-0637-x","volume":"38","author":"T Motohara","year":"2019","unstructured":"Motohara T, et al. An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment. Oncogene. 2019;38(16):2885\u201398.","journal-title":"Oncogene"},{"issue":"8","key":"1046_CR5","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1158\/0008-5472.CAN-19-1999","volume":"80","author":"A Mukherjee","year":"2020","unstructured":"Mukherjee A, et al. Adipocyte-induced FABP4 expression in ovarian cancer cells promotes metastasis and mediates carboplatin resistance. Cancer Res. 2020;80(8):1748\u201361.","journal-title":"Cancer Res"},{"issue":"17","key":"1046_CR6","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/s41388-017-0093-z","volume":"37","author":"A Ladanyi","year":"2018","unstructured":"Ladanyi A, et al. Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis. Oncogene. 2018;37(17):2285\u2013301.","journal-title":"Oncogene"},{"issue":"1","key":"1046_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-019-2221-x","volume":"11","author":"J Zhao","year":"2020","unstructured":"Zhao J, et al. SIK2 enhances synthesis of fatty acid and cholesterol in ovarian cancer cells and tumor growth through PI3K\/Akt signaling pathway. Cell Death Dis. 2020;11(1):1\u201313.","journal-title":"Cell Death Dis"},{"issue":"2","key":"1046_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ccell.2016.06.020","volume":"30","author":"F Miranda","year":"2016","unstructured":"Miranda F, et al. Salt-inducible kinase 2 couples ovarian cancer cell metabolism with survival at the adipocyte-rich metastatic niche. Cancer Cell. 2016;30(2):273\u201389.","journal-title":"Cancer Cell"},{"issue":"11","key":"1046_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107762","volume":"31","author":"CJ de Witte","year":"2020","unstructured":"de Witte CJ, et al. Patient-derived ovarian cancer organoids mimic clinical response and exhibit heterogeneous inter-and intrapatient drug responses. Cell Rep. 2020;31(11):107762.","journal-title":"Cell Rep"},{"issue":"5","key":"1046_CR10","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/s41591-019-0422-6","volume":"25","author":"O Kopper","year":"2019","unstructured":"Kopper O, et al. An organoid platform for ovarian cancer captures intra-and interpatient heterogeneity. Nat Med. 2019;25(5):838\u201349.","journal-title":"Nat Med"},{"issue":"1","key":"1046_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-16432-0","volume":"11","author":"K L\u00f5hmussaar","year":"2020","unstructured":"L\u00f5hmussaar K, et al. Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids. Nat Commun. 2020;11(1):1\u201314.","journal-title":"Nat Commun"},{"key":"1046_CR12","doi-asserted-by":"crossref","unstructured":"Yang J, et al. Application of ovarian cancer organoids in precision medicine: key challenges and current opportunities. Front Cell Dev Biol. 2021;9:2004.","DOI":"10.3389\/fcell.2021.701429"},{"issue":"12","key":"1046_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167385","volume":"11","author":"IA Okkelman","year":"2016","unstructured":"Okkelman IA, et al. Use of fluorescence lifetime imaging microscopy (FLIM) as a timer of cell cycle S phase. PLoS One. 2016;11(12):e0167385.","journal-title":"PLoS One"},{"key":"1046_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101420","volume":"30","author":"IA Okkelman","year":"2020","unstructured":"Okkelman IA, et al. A deeper understanding of intestinal organoid metabolism revealed by combining fluorescence lifetime imaging microscopy (FLIM) and extracellular flux analyses. Redox Biol. 2020;30:101420.","journal-title":"Redox Biol"},{"issue":"3","key":"1046_CR15","doi-asserted-by":"publisher","first-page":"330a","DOI":"10.1016\/j.bpj.2019.11.1846","volume":"118","author":"R Dmitriev","year":"2020","unstructured":"Dmitriev R, Okkelman I. Multi-parameter fluorescence lifetime imaging microscopy (FLIM) for imaging metabolism in the intestinal Organoids model. Biophys J. 2020;118(3):330a.","journal-title":"Biophys J"},{"key":"1046_CR16","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3389\/fonc.2020.00553","volume":"10","author":"JT Sharick","year":"2020","unstructured":"Sharick JT, et al. Metabolic heterogeneity in patient tumor-derived organoids by primary site and drug treatment. Front Oncol. 2020;10:553.","journal-title":"Front Oncol."},{"key":"1046_CR17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.copbio.2014.08.007","volume":"31","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Yang Y. Profiling metabolic states with genetically encoded fluorescent biosensors for NADH. Curr Opin Biotechnol. 2015;31:86\u201392.","journal-title":"Curr Opin Biotechnol"},{"issue":"7","key":"1046_CR18","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/nmeth.4306","volume":"14","author":"R Tao","year":"2017","unstructured":"Tao R, et al. Genetically encoded fluorescent sensors reveal dynamic regulation of NADPH metabolism. Nat Methods. 2017;14(7):720\u20138.","journal-title":"Nat Methods"},{"key":"1046_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-1-62703-622-1_7","volume-title":"Fluorescent protein-based biosensors","author":"YP Hung","year":"2014","unstructured":"Hung YP, Yellen G. Live-cell imaging of cytosolic NADH\u2013NAD+ redox state using a genetically encoded fluorescent biosensor. In: Fluorescent protein-based biosensors: Springer; 2014. p. 83\u201395."},{"issue":"5","key":"1046_CR20","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.cmet.2015.04.009","volume":"21","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, et al. SoNar, a highly responsive NAD+\/NADH sensor, allows high-throughput metabolic screening of anti-tumor agents. Cell Metab. 2015;21(5):777\u201389.","journal-title":"Cell Metab"},{"issue":"2","key":"1046_CR21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nmeth.1288","volume":"6","author":"J Berg","year":"2009","unstructured":"Berg J, Hung YP, Yellen G. A genetically encoded fluorescent reporter of ATP: ADP ratio. Nat Methods. 2009;6(2):161\u20136.","journal-title":"Nat Methods"},{"issue":"1","key":"1046_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-018-06533-2","volume":"9","author":"B Steinhorn","year":"2018","unstructured":"Steinhorn B, et al. Chemogenetic generation of hydrogen peroxide in the heart induces severe cardiac dysfunction. Nat Commun. 2018;9(1):1\u201310.","journal-title":"Nat Commun"},{"issue":"8","key":"1046_CR23","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3390\/biomedicines9081021","volume":"9","author":"JW Gorski","year":"2021","unstructured":"Gorski JW, et al. Utilizing patient-derived epithelial ovarian Cancer tumor Organoids to predict carboplatin resistance. Biomedicines. 2021;9(8):1021.","journal-title":"Biomedicines"},{"issue":"4","key":"1046_CR24","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nmeth866","volume":"3","author":"VV Belousov","year":"2006","unstructured":"Belousov VV, et al. Genetically encoded fluorescent indicator for intracellular hydrogen peroxide. Nat Methods. 2006;3(4):281\u20136.","journal-title":"Nat Methods"},{"issue":"1","key":"1046_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-57821-1","volume":"10","author":"E Fern\u00e1ndez-Puente","year":"2020","unstructured":"Fern\u00e1ndez-Puente E, et al. Expression and functional analysis of the hydrogen peroxide biosensors HyPer and HyPer2 in C2C12 myoblasts\/myotubes and single skeletal muscle fibres. Sci Rep. 2020;10(1):1\u201315.","journal-title":"Sci Rep"},{"issue":"1","key":"1046_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijc.26306","volume":"130","author":"AK Maiti","year":"2012","unstructured":"Maiti AK. Genetic determinants of oxidative stress-mediated sensitization of drug-resistant cancer cells. Int J Cancer. 2012;130(1):1\u20139.","journal-title":"Int J Cancer"},{"issue":"12","key":"1046_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081859","volume":"8","author":"A Nowicka","year":"2013","unstructured":"Nowicka A, et al. Human omental-derived adipose stem cells increase ovarian cancer proliferation, migration, and chemoresistance. PLoS One. 2013;8(12):e81859.","journal-title":"PLoS One"},{"issue":"10","key":"1046_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076871","volume":"8","author":"G Schwank","year":"2013","unstructured":"Schwank G, et al. Generation of BAC transgenic epithelial organoids. PLoS One. 2013;8(10):e76871.","journal-title":"PLoS One"},{"issue":"4","key":"1046_CR29","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1038\/s41596-020-00474-1","volume":"16","author":"JF Dekkers","year":"2021","unstructured":"Dekkers JF, et al. Long-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoids. Nat Protoc. 2021;16(4):1936\u201365.","journal-title":"Nat Protoc"},{"issue":"2","key":"1046_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ab.2010.04.031","volume":"404","author":"S Dietmair","year":"2010","unstructured":"Dietmair S, et al. Towards quantitative metabolomics of mammalian cells: development of a metabolite extraction protocol. Anal Biochem. 2010;404(2):155\u201364.","journal-title":"Anal Biochem"},{"issue":"2","key":"1046_CR31","doi-asserted-by":"publisher","first-page":"188527","DOI":"10.1016\/j.bbcan.2021.188527","volume":"1875","author":"S Rauth","year":"2021","unstructured":"Rauth S, et al. Recent advances in organoid development and applications in disease modeling. Biochim Biophys Acta Rev Cancer. 2021;1875(2):188527.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"1046_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-27332-2","volume":"12","author":"Y Nasu","year":"2021","unstructured":"Nasu Y, et al. A genetically encoded fluorescent biosensor for extracellular L-lactate. Nat Commun. 2021;12(1):1\u201312.","journal-title":"Nat Commun"},{"issue":"9","key":"1046_CR33","first-page":"1011","volume":"2","author":"S Bose","year":"2021","unstructured":"Bose S, Clevers H, Shen X. Promises and challenges of Organoid-guided precision medicine. Med (N Y). 2021;2(9):1011\u201326.","journal-title":"Med (N Y)"},{"issue":"5","key":"1046_CR34","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1053\/j.gastro.2011.07.050","volume":"141","author":"T Sato","year":"2011","unstructured":"Sato T, et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. Gastroenterology. 2011;141(5):1762\u201372.","journal-title":"Gastroenterology"},{"issue":"8","key":"1046_CR35","doi-asserted-by":"publisher","first-page":"eabm1831","DOI":"10.1126\/sciadv.abm1831","volume":"8","author":"K Zhang","year":"2022","unstructured":"Zhang K, et al. Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer. Sci Adv. 2022;8(8):eabm1831.","journal-title":"Sci Adv"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-022-01046-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-022-01046-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-022-01046-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T20:38:32Z","timestamp":1666557512000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-022-01046-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,20]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1046"],"URL":"https:\/\/doi.org\/10.1186\/s13048-022-01046-5","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,20]]},"assertion":[{"value":"15 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"X.S. is a co-founder of Xilis, Inc. This manuscript does not have any overlap with Xilis\u2019s commercial interests. The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}